Covid 19 vaccine

As per reports by state media the patent was issued on August 11

It would be producing about five million doses a month by December-January, Interfax said

Three potential indigenous vaccines under development and as soon as scientists give the go-ahead, the country is ready for mass…

SK bioscience will manufacture the vaccine antigen component for use in the final drug product globally during the pandemic period

The deal between AstraZeneca and mAbxience of the INSUD Group includes technology to initially produce 150 million doses of the…

Experts also deliberated on creation of a digital infrastructure for inventory management and delivery mechanism of the vaccine…

The committee would chalk out strategies on the aspects of prioritisation of the vaccine administration once it is developed, roll…

The vaccine uses adenovirus type-5 (Ad5) to carry genetic material from the coronavirus into the body

As per the deal, AstraZeneca will deliver the first 100 million doses this year and 200 million doses by the end of 2021

Serum Institute of India will have exclusive rights for the vaccine in India during the term of the deal